Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Colorectal cancer (CRC) is a major public health issue, with over 43,000 new cases and nearly 17,700 deaths annually in France. The overall survival rate is currently 63%. It is much higher for early ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Vaccination against the Human Papillomavirus (HPV) as well as improving access to DNA-based screening is crucial to eliminate ...

The U.S. Food and Drug Administration has approved the first DNA test that serves as a primary screening for the human papillomavirus in women ages 25 and older. The DNA test, cobas HPV Test ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...

In this study, we evaluate the multitarget stool DNA test as a tool for screening. The primary aim was to determine the performance characteristics of the DNA test in the detection of colorectal ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...